<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
KNSA
Kiniksa
$
()


  • Kiniksa sees FY24 ARCALYST product revenue $370M-$390M

    Today - 07:32am
  • Kiniksa reports Q1 EPS (25c), consensus (16c)

    Today - 07:31am
  • Kiniksa announces development indication for abiprubart

    4/2/2024 - 07:46am
  • Fly Intel: Pre-market Movers

    2/28/2024 - 09:00am
  • Kiniksa reports Q4 EPS 35c, consensus (14c)

    2/28/2024 - 07:32am
  • Kiniksa expects cash to fund operating plan into at least 2027

    1/4/2024 - 07:42am
  • Kiniksa says abiprubart Phase 2 trial meets primary efficacy endpoint

    1/4/2024 - 07:42am
  • Kiniksa sees 2024 ARCALYST net product revenue $360M-$380M

    1/4/2024 - 07:38am
  • Kiniksa reports Q4 ARCALYST net product revenue $71.2M

    1/4/2024 - 07:34am
  • Kiniksa price target raised by $2 at Wedbush, here's why

    1/2/2024 - 08:02am
  • Kiniksa expects cash to fund operating plan into at least 2027

    10/31/2023 - 07:33am
  • Kiniksa sees 2023 ARCALYST net product revenue $220M-$230M

    10/31/2023 - 07:33am
  • Kiniksa reports Q3 EPS (20c), consensus (17c)

    10/31/2023 - 07:32am
  • What You Missed On Wall Street On Tuesday

    7/25/2023 - 16:27pm
  • What You Missed On Wall Street This Morning

    7/25/2023 - 11:58am
dynamic_feed Breaking News